The market treating brain tumors worldwide had a market value of US$ 2,946.17 million in 2022, and it is anticipated to reach US$ 5,904.82 million by 2032, growing at a CAGR of 7.2%. Key factors that are anticipated to foster the growth of the brain tumor diagnosis market globally include the rising prevalence of such cancer and the expanding geriatric population. The global demand for brain surgery treatment is anticipated to grow at a CAGR of 7.2%between 2022 and 2032, reaching a total of US$ 5,904.82 Million in 2032. (FMI).Sales increased significantly between 2017 and 2021, with a 6.8% CAGR.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
